SEARCH

SEARCH BY CITATION

References

  • Abdul M, Hoosein N (2002) Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 9: 961- 964
  • Abdul M, Hoosein N (2006) Reduced Kv 1.3 potassium channel expression in human prostate cancer. J. Membr. Biol. 214: 99- 102
  • Abdul M, Santo A, Hoosein N (2003) Activity of potassium channel blockers in breast cancer. Anticancer Res. 23: 3347- 3351
  • Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503- 511
  • Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B, Andrews DW (2005) Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO. J. 24: 2096- 2103
  • Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti O (2009) Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16: 66- 93
  • Artym VV, Petty HR (2002) Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J. Gen. Physiol. 120: 29- 37
  • Bednarczyk P, Kowalczyk JE, Beresewicz M, Dołowy K, Szewczyk A, Zabłocka B (2010) Identification of a voltage-gated potassium channel in gerbil hippocampal mitochondria. Biochem. Biophys. Res. Commun. 397: 614- 620
  • Bielanska J, Hernández-Losa J, Pérez-Verdaguer M, Moline T, Somoza R, Ramón Y, Cajal S, Condom E, Ferreres JC, Felipe A (2009) Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr. Cancer Drug Targets 9: 904- 914
  • Brevet M, Fucks D, Chatelain D, Regimbeau JM, Delcenserie R, Sevestre H Ouadid-Ahidouch H (2009) Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of Kv1.3 gene promoter methylation. Pancreas 38: 649- 654
  • Buytaert E, Callewaert G, Vandenheede JR, Agostinis P (2006a) Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2: 238- 240
  • Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J, Agostinis P (2006b) Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J. 20: 756- 758
  • Caffieri S, Di Lisa F, Bolesani F, Facco M, Semenzato G, Dall'Acqua F Canton (2007) The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy. Blood 109: 4988- 4994
  • Cahalan MD, Chandy KG (2009) The functional network of ion channels in T lymphocytes. Immunol. Rev. 231: 59- 87
  • Cheng Y, Debska-Vielhaber G, Siemen D (2010) Interaction of mitochondrial potassium channels with the permeability transition pore. FEBS Lett. 584: 2005- 2012
  • Falkson CI, Falkson G (1999) A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma. Oncology 57: 232- 235
  • Fanger CM, Rauer H, Neben AL, Miller MJ, Rauer H, Wulff H, Rosa JC, Ganellin CR, Chandy KG, Cahalan MD (2001) Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J. Biol. Chem. 276: 12249- 12256
  • Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ, Garcia ML (1993) Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J. Biol. Chem. 268: 18866- 18874
  • Gulbins E, Sassi N, Grassmè H, Zoratti M, Szabò I (2010) Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim. Biophys. Acta Bioenerg. 1797: 1251- 1259
  • Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stühmer W, et al (2005) International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57: 473- 508
  • Han J, Goldstein LA, Gastman BR, Rabinovitz A, Wang GQ, Fang B, Rabinowich H (2004) Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells. Leukemia 18: 1671- 1680
  • Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M (2000) Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc. Natl. Acad. Sci. USA 97: 10872- 10877
  • Jang SH, Kang KS, Ryu PD, Lee SY (2009) Kv1.3 voltage-gated K+ channel subunit as potential diagnostic marker and therapeutic target for breast cancer. BMB Rep. 42: 535- 539
  • Jang SH, Choi SY, Ryu PS, Lee SY (2011) Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur. J. Pharmacol. 651: 26- 32
  • Koeberle PD, Wang Y, Schlichter LC (2009) Kv1.1 and Kv1.3 contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Diff. 17: 134- 144
  • Konstantinov AA, Peskin AV, Popova EY, Khomutov GB, Ruuge EK (1987) Superoxide generation by the respiratory chain of tumor mitochondria. Biochim. Biophys. Acta 894: 1- 10
  • Lan M, Shi Y, Han Z, Hao Z, Pan Y, Liu N, Guo C, Hong L, Wang J, Qiao T, et al (2005) Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol. Ther. 4: 1342- 1347
  • Leanza L, Miazzi C, Ferraro P, Reichard P, Bianchi V (2010) Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints. Exp. Cell Res. 316: 3443- 3453
  • LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A (2002) Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat. Med. 8: 274- 281
  • McCloskey C, Jones S, Amisten S, Snowden RT, Kaczmarek LK, Erlinge D, Goodall AH, Forsythe ID Mahaut-Smith MP (2010) Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count. J. Physiol. 588: 1399- 1406
  • McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 94: 2345- 2349
  • Meijerink JP, Mensink EJ, Wang K, Sedlak TW, Slöetjes AW, de Witte T, Waksman G, Korsmeyer SJ (1998) Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91: 2991- 2997
  • Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140: 313- 326
  • Oberley LW, Bize IB, Sahu SK, Leuthauser SW, Gruber HE (1978) Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. J. Natl. Cancer Inst. 61: 375- 379
  • Pellicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist. Updates 7: 97- 110
  • Pereira LE, Villinger F, Wulff H, Sankaranarayanan A, Raman G, Ansari AA (2007) Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in Rhesus Macaques. Exp. Biol. Med. 232: 1338- 1354
  • Pourgholami MH, Lu Y, Wang L, Stephens RW, Morris DL (2004) Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol. Cancer Lett. 207: 37- 47
  • Preussat K, Beetz C, Schrey M, Kraft R, Wölfl S, Kalff R, Patt S (2003) Expression of voltage-gated potassium channels Kv 1.3 and Kv 1.5 in human gliomas. Neurosci. Lett. 346: 33- 36
  • Puttini M, Coluccia AM, Boschelli F, Cleris L, Marchesi E, Donella-Deana A, Ahmed S, Redaelli S, Piazza R, Magistroni V, et al (2006) In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells. Cancer Res. 66: 11314- 11322
  • Ren YR, Pan F, Parvez S, Fleig A, Chong CR, Xu J, Dang Y, Zhang J, Jiang H, Penner R, et al (2008) Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS One 3: e4009
  • Ruff P, Chasen MR, Long JEH van Rensburg CEJ (1998) A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma. Ann. Oncol. 9: 217- 219
  • Sassi N, De Marchi U, Fioretti B, Biasutto L, Gulbins E, Francolini F, Szabò I, Zoratti M (2010) An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtKCa3.1. Biochim. Biophys. Acta Bioenerg. 1797: 1260- 1267
  • Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hansel W, Wulff H (2005) Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol. Pharmacol. 68: 1254- 1270
  • Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T, Korsmeyer SJ (2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300: 135- 139
  • Smith GA, Tsui HW, Newell EW, Jiang X, Zhu XP, Tsui FW, Schlichter LC (2002) Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells. J. Biol. Chem. 277: 18528- 18534
  • Sri-Pathmanathan RM, Plumb JA, Fearon KC (1994) Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo. Int. J. Cancer 56: 900- 905
  • Szabò I, Gulbins E, Apfel H, Zhang X, Barth P, Busch AE, Schlottmann K, Pongs O, Lang F (1996) Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation. J. Biol. Chem. 271: 20465- 20469
  • Szabò I, Bock J, Jekle A, Soddemann M, Adams C, Lang F, Zoratti M, Gulbins E (2005) A novel potassium channel in lymphocyte mitochondria. J. Biol. Chem. 280: 12790- 12798
  • Szabò I, Bock J, Grassmé H, Soddemann M, Wilker B, Lang F, Zoratti M, Gulbins E (2008) Mitochondrial potassium channel Kv1.3 mediates Bax induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. USA 105: 14861- 14866
  • Szabò I, Zoratti M, Gulbins E (2010) Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett. 584: 2049- 2056
  • Szabò I, Soddemann M, Leanza L, Zoratti M, Gulbins E (2011) Single point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts—novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Diff. 18: 427- 438
  • Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51: 794- 798
  • Van Driel BE, Lyon H, Hoogenraad DC, Anten S, Hansen U Van Noorden CJ (1997) Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Radic. Biol. Med. 23: 435- 444
  • Van Rensburg CEJ, Van Staden AM, Anderson R (1993) The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms I. Cancer Res. 53: 318- 323
  • Van Rensburg EJ, Joone G, Anderson R (1998) α-Tocopherol antagonizes the multidrug resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669. Cancer Lett. 127: 107- 112
  • Vennekamp J, Wulff H, Beeton C, Calabresi PA, Grissmer S, Hänsel W, Chandy KG (2004) Kv1.3 blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol. Pharmacol. 65: 1364- 1374
  • Wang GQ, Gastman BR, Wieckowski E, Goldstein LA, Gambotto A, Kim TH, Fang B, Rabinovitz A, Yin XM, Rabinowich H (2001) A role for mitochondrial Bak in apoptotic response to anticancer drugs. J. Biol. Chem. 276: 34307- 34317
  • Yu SP, Kerchner GA (1998) Endogenous voltage-gated potassium channels in human embryonic kidney (HEK293) cells. J. Neurosi. Res. 52: 612- 617
  • Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P (2003) Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 101: 4098- 4104